Pharmacovigilance analytics is undergoing a transformation from reactive adverse event case processing toward proactive, signal-driven safety surveillance powered by advanced analytics capabilities that are dramatically expanding the data sources, analytical methods, and detection sensitivity available for identifying safety signals that could affect the millions of patients who receive...